Mostrar el registro sencillo del ítem

Artículo

dc.creatorGrosso, Robertoes
dc.creatorPaz Báñez, María Violante dees
dc.date.accessioned2022-01-05T13:54:34Z
dc.date.available2022-01-05T13:54:34Z
dc.date.issued2021
dc.identifier.citationGrosso, R. y Paz Báñez, M.V.d. (2021). Thiolated-polymer-based nanoparticles as an avant-garde approach for anticancer therapies—Reviewing thiomers from chitosan and hyaluronic acid. Pharmaceutics, 13 (6), 854.
dc.identifier.issn1999-4923es
dc.identifier.urihttps://hdl.handle.net/11441/128676
dc.description.abstractThiomers (or thiolated polymers) have broken through as avant-garde approaches in anticancer therapy. Their distinguished reactivity and properties, closely linked to their final applications, justify the extensive research conducted on their preparation and use as smart drug-delivery systems (DDSs). Multiple studies have demonstrated that thiomer-rich nanoformulations can overcome major drawbacks found when administering diverse active pharmaceutical ingredients (APIs), especially in cancer therapy. This work focuses on providing a complete and concise review of the synthetic tools available to thiolate cationic and anionic polymers, in particular chitosan (CTS) and hyaluronic acid (HA), respectively, drawing attention to the most successful procedures. Their chemical reactivity and most relevant properties regarding their use in anticancer formulations are also discussed. In addition, a variety of NP formation procedures are outlined, as well as their use in cancer therapy, particularly for taxanes and siRNA. It is expected that the current work could clarify the main synthetic strategies available, with their scope and drawbacks, as well as provide some insight into thiomer chemistry. Therefore, this review can inspire new research strategies in the development of efficient formulations for the treatment of cancer.es
dc.formatapplication/pdfes
dc.format.extent48 p.es
dc.language.isoenges
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es
dc.relation.ispartofPharmaceutics, 13 (6), 854.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAnticancer therapyes
dc.subjectChitosanes
dc.subjectDisulfide bondses
dc.subjectEPR effectes
dc.subjectGlutathionees
dc.subjectHyaluronic acides
dc.subjectMucoadhesiones
dc.subjectNanoformulationses
dc.subjectNanotechnologyes
dc.subjectPermeation enhanceres
dc.subjectPreactivatedes
dc.subjectSiRNAes
dc.subjectSmart DDSes
dc.subjectTaxaneses
dc.subjectThiolated polymerses
dc.subjectThiolationes
dc.subjectThiomerses
dc.titleThiolated-polymer-based nanoparticles as an avant-garde approach for anticancer therapies—Reviewing thiomers from chitosan and hyaluronic acides
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Química Orgánica y Farmacéuticaes
dc.relation.publisherversionhttps://doi.org/10.3390/pharmaceutics13060854es
dc.identifier.doi10.3390/pharmaceutics13060854es
dc.journaltitlePharmaceuticses
dc.publication.volumen13es
dc.publication.issue6es
dc.publication.initialPage854es

FicherosTamañoFormatoVerDescripción
Thiolated-Polymer-Based Nanopa ...10.13MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional